Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / glancy prongay murray llp announces investigation of

NKTR - Glancy Prongay & Murray LLP Announces Investigation of Nektar Therapeutics (NKTR)

Nektar Therapeutics

Glancy Prongay & Murray LLP (“GPM”) announces its investigation of Nektar Therapeutics (Nasdaq: NKTR) concerning the Company and its directors’ and officers’ possible violations of state laws.

If you own Nektar Therapeutics stock, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Tom Kennedy, of GPM, 230 Park Avenue, Suite 358, New York, NY 10169 at tkennedy@glancylaw.com , or at 212-682-5340. If you inquire by email please include your mailing address, telephone number, and the number of shares purchased and held.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230201005688/en/

Glancy Prongay & Murray LLP
Tom Kennedy, 212-682-5340
tkennedy@glancylaw.com
www.glancylaw.com

Stock Information
Company Name: Nektar Therapeutics
Stock Symbol: NKTR
Market: NASDAQ
Website: nektar.com
Menu
NKTR NKTR Quote NKTR Short NKTR News NKTR Articles NKTR Message Board
Get NKTR Alerts

News, Short Squeeze, Breakout and More Instantly...